Innate Pharma S.A. - American Depositary Shares (IPHA)

1.6800
-0.0200 (-1.18%)
NASDAQ · Last Trade: Feb 19th, 3:12 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Number of Shares and Voting Rights of Innate Pharma as of February 19, 2026
Regulatory News:
By Innate Pharma SA · Via Business Wire · February 19, 2026
Innate Pharma to Participate in the Leerink Partners Global Healthcare Conference
Regulatory News:
By Innate Pharma SA · Via Business Wire · February 18, 2026
Number of Shares and Voting Rights of Innate Pharma as of December 18, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · December 22, 2025
Innate Pharma Releases Its 2026 Financial Calendar
Regulatory News:
By Innate Pharma SA · Via Business Wire · December 11, 2025
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · November 28, 2025
Innate Pharma to Present at Jefferies Global Healthcare Conference
Regulatory News:
By Innate Pharma SA · Via Business Wire · November 17, 2025
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
Regulatory News:
By Innate Pharma SA · Via Business Wire · November 13, 2025
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
Regulatory News:
By Innate Pharma SA · Via Business Wire · November 10, 2025
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
Regulatory News:
By Innate Pharma SA · Via Business Wire · November 5, 2025
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · October 14, 2025
Innate Pharma Reports First Half 2025 Business Update and Financial Results
Regulatory News:
By Innate Pharma SA · Via Business Wire · September 17, 2025
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event
Regulatory News:
By Innate Pharma SA · Via Business Wire · September 15, 2025
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
Regulatory News:
By Innate Pharma SA · Via Business Wire · September 10, 2025
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · September 2, 2025
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
Regulatory news:
By Innate Pharma SA · Via Business Wire · August 4, 2025
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
Regulatory News:
By Innate Pharma SA · Via Business Wire · July 29, 2025
Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
Regulatory News:
By Innate Pharma SA · Via Business Wire · July 4, 2025
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
Regulatory News:
By Innate Pharma SA · Via Business Wire · June 17, 2025
Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress
Regulatory News:
By Innate Pharma SA · Via Business Wire · June 13, 2025
Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
Regulatory News:
By Innate Pharma SA · Via Business Wire · May 27, 2025
Outcome of Innate Pharma’s 2025 Annual General Meeting
Regulatory News:
By Innate Pharma SA · Via Business Wire · May 23, 2025
Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
Regulatory News:
By Innate Pharma SA · Via Business Wire · May 23, 2025
Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting
Regulatory News:
By Innate Pharma SA · Via Business Wire · May 19, 2025
Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress
Regulatory News:
By Innate Pharma SA · Via Business Wire · May 15, 2025
Innate Pharma Reports First Quarter 2025 Business Update and Financial Results
Regulatory News:
By Innate Pharma SA · Via Business Wire · May 13, 2025